NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Aytu Biopharma Inc (NASDAQ: AYTU)

 
AYTU Technical Analysis
5
As on 16th May 2025 AYTU STOCK Price closed @ 2.13 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 2.75 & Strong Sell for SHORT-TERM with Stoploss of 2.68 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

AYTUSTOCK Price

Open 2.23 Change Price %
High 2.46 1 Day -0.46 -17.76
Low 2.06 1 Week 0.92 76.03
Close 2.13 1 Month 1.06 99.07
Volume 2706674 1 Year -0.39 -15.48
52 Week High 3.36 | 52 Week Low 1.00
 
NASDAQ USA Most Active Stocks
AFMD 0.28 211.11%
AMRS 0.14 100.00%
HCTI 0.01 -75.00%
BON 0.06 20.00%
PLUG 0.77 10.00%
NVDA 135.40 0.42%
AGMH 0.07 16.67%
GNLN 0.01 0.00%
LCID 2.84 5.58%
LMDX 0.02 0.00%
 
NASDAQ USA Top Gainers Stocks
KTRA 6.30 2763.64%
IDRA 8.64 1909.30%
REDU 3.41 1075.86%
CTXRW 0.14 600.00%
AFMD 0.28 211.11%
NDRAW 0.03 200.00%
INZY 3.95 178.17%
GLSPT 33.43 138.62%
BIOC 0.07 133.33%
BCAC 22.71 125.30%
 
NASDAQ USA Top Losers Stocks
CTHR 0.02 -98.00%
OTIC 0.01 -91.67%
PTRAW 0.23 -89.59%
TBIO 0.01 -83.33%
NBSTU 2.00 -82.44%
ZWZZT 10.00 -75.50%
HCTI 0.01 -75.00%
SRAX 0.10 -73.68%
ACAQ-UN 2.50 -73.49%
AGBA 0.35 -71.31%
 
 
AYTU
Daily Charts
AYTU
Intraday Charts
Whats New @
Bazaartrend
AYTU
Free Analysis
 
AYTU Important Levels Intraday
RESISTANCE2.90
RESISTANCE2.65
RESISTANCE2.50
RESISTANCE2.35
SUPPORT1.91
SUPPORT1.76
SUPPORT1.61
SUPPORT1.36
 
AYTU Forecast May 2025
4th UP Forecast3.46
3rd UP Forecast3.03
2nd UP Forecast2.77
1st UP Forecast2.51
1st DOWN Forecast1.75
2nd DOWN Forecast1.49
3rd DOWN Forecast1.23
4th DOWN Forecast0.8
 
AYTU Weekly Forecast
4th UP Forecast2.73
3rd UP Forecast2.54
2nd UP Forecast2.42
1st UP Forecast2.30
1st DOWN Forecast1.96
2nd DOWN Forecast1.84
3rd DOWN Forecast1.72
4th DOWN Forecast1.53
 
AYTU Forecast2025
4th UP Forecast6.95
3rd UP Forecast5.4
2nd UP Forecast4.45
1st UP Forecast3.49
1st DOWN Forecast0.77
2nd DOWN Forecast-0.19
3rd DOWN Forecast-1.14
4th DOWN Forecast-2.69
 
 
AYTU Other Details
Segment EQ
Market Capital 67785544.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
AYTU Address
AYTU
 
AYTU Latest News
 
Your Comments and Response on Aytu Biopharma Inc
 
AYTU Business Profile
Aytu Biopharma, Inc., a specialty pharmaceutical company, focuses on developing and commercializing novel therapeutics and consumer healthcare products the United States and internationally. The company offers Adzenys XR-ODT for the treatment of attention deficit hyperactivity disorder (ADHD) in patients from 6 years and older; Cotempla XR-ODT for the treatment of ADHD in patients from 6 to 17 years old; and Adzenys ER, an oral suspension for the treatment of ADHD in patients from 6 years and older. It also provides Karbinal ER, a carbinoxamine oral suspension for the treatment of seasonal and perennial allergies; Poly-Vi-Flor and Tri-Vi-Flor prescription supplements for infants and children for the treatment of fluoride deficiency; Tuzistra XR, a prescription antitussive consisting of codeine polistirex and chlorpheniramine polistirex in an oral suspension; and ZolpiMist, an oral spray for the treatment of insomnia. The company was formerly known as Aytu BioScience, Inc. and changed its name to Aytu Biopharma, Inc. in March 2021. Aytu Biopharma, Inc. was incorporated in 2015 and is headquartered in Englewood, Colorado. Address: 373 Inverness Parkway, Englewood, CO, United States, 80112
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service